Riskpilot← Back to searchSign inGet full accessAPE APOTEK AS
ASActiveOrg 922772010Tempevegen 22, 7031 TrondheimRetail sale of pharmaceutical products · NACE 4773Est. 201911 employees
Revenue 2024
NOK 15M
+26% vs 2023
EBITDA margin
8.2%
+1883% vs 2023
Equity ratio
43.8%
Financial strength
Net profit 2024
NOK 1,1M
+1928% vs 2023
| Revenue | NOK 15M | +26% |
| EBITDA | NOK 1,2M | +1883% |
| Net profit | NOK 1,1M | +1928% |
| Total assets | NOK 3,7M | -22% |
| Equity | NOK 1,6M | +221% |
| Employees | 11 | — |
Legal name
APE APOTEK AS
Org number
922772010
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
21. mai 2019
Share capital
NOK 1 530 000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Et utsalgssted for legemidler, handelsvarer m.m
Address
Tempevegen 22, 7031 Trondheim
Phone
+4773942000
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 8 354 | 10 702 | 10 848 | 11 889 | 14 962 |
| Staff expenses | −2 082 | −1 877 | −2 100 | −2 258 | −2 142 |
| EBITDA | −104 | 117 | −86 | 62 | 1 222 |
| Depreciation & amort. | −148 | −148 | −89 | −81 | −80 |
| EBIT | −252 | −31 | −175 | −19 | 1 141 |
| Net financials | −55 | −42 | −41 | −41 | −10 |
| Profit before tax | −307 | −73 | −216 | −60 | 1 131 |
| Tax | −0 | −0 | −0 | −0 | 28 |
| Net profit | −307 | −73 | −216 | −60 | 1 103 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 659 | 4 121 | 2 423 | 4 692 | 3 663 |
| Equity | −651 | −724 | −940 | 500 | 1 604 |
| Long-term debt | 1 579 | 3 235 | 2 185 | 322 | 28 |
| Short-term debt | 2 731 | 1 609 | 1 178 | 3 870 | 2 032 |
| Total debt | 4 309 | 4 845 | 3 363 | 4 192 | 2 060 |
EBITDA margin
8.2%
This company
15.8%
Market median
-48% vs market
20202024
Equity ratio
43.8%
This company
38.2%
Market median
+15% vs market
20202024
Return on equity
68.8%
This company
18.4%
Market median
+274% vs market
20202024
Net profit margin
7.4%
This company
8.1%
Market median
-9% vs market
20202024
Asset turnover
4.08×
This company
1.12×
Market median
+264% vs market
20202024
Debt / equity
1.28×
This company
0.62×
Market median
-106% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Chairman | 2024 | |
| Former (1) | ||
| Chairman | 2021 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of APE APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christer Andersson Jenssen | Board of Directors | 0 companies |
| Juni Magritt Tjora | Chairman | 0 companies |
| Tiago Sebastiao Moreira Carneiro | Chairman | 0 companies |
| Mina Minh-Anh Nguyen | Chairman | 0 companies |